Organigram Global Inc. Common Shares earnings per share and revenue
On 16 de dez. de 2025, OGI reported earnings of -0.33 USD per share (EPS) for Q4 25, missing the estimate of -0.01 USD, resulting in a -2519.05% surprise. Revenue reached 80.06 milhão, compared to an expected 73.75 milhão, with a 8.56% difference. The market reacted with a +8.89% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analistas forecast an EPS of -0.01 USD, with revenue projected to reach 74.11 milhão USD, implying an diminuir of -96.97% EPS, and diminuir of -7.43% in Revenue from the last quarter.
FAQ
What were Organigram Global Inc. Common Shares's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Organigram Global Inc. Common Shares reported EPS of -$0.33, missing estimates by -2519.05%, and revenue of $80.06M, 8.56% above expectations.
How did the market react to Organigram Global Inc. Common Shares's Q4 2025 earnings?
The stock price moved up 8.89%, changed from $1.80 before the earnings release to $1.96 the day after.
When is Organigram Global Inc. Common Shares expected to report next?
The next earning report is scheduled for 09 de fev. de 2026.
What are the forecasts for Organigram Global Inc. Common Shares's next earnings report?
Based on 3
analistas, Organigram Global Inc. Common Shares is expected to report EPS of -$0.01 and revenue of $74.11M for Q1 2026.